Professional Documents
Culture Documents
December 2019
December 2019
December 2019
Kotak Securities – Private Client Group Please see the Disclosure/Disclaimer on the last page For Private Circulation 2
Market Strategy
December 2019
9.0%
7.0%
6.0% 4.6%
3.8%
2.6%
3.0% 1.9% 1.8%
1.0%
0.3%
0.0%
-3.0% -1.7%
-3.1%
-6.0% -4.0% -4.2%
-9.0% -7.8%
FIEM Industries Ltd 433 549 26.9 5,694 46.0 54.9 9.0 19.3 9.4 7.9 12.0 13.0
Escorts Ltd 637 1,030 61.6 78,106 52.0 63.0 (4.5) 21.1 12.3 10.1 13.6 14.5
Jyothy Labs Ltd 179 200 11.8 65,712 6.2 7.0 10.6 13.6 28.9 25.5 16.6 17.6
Sun Pharmaceutical Industries 450 480 6.7 1,079,338 19.0 23.8 17.5 25.3 23.7 18.9 10.5 11.3
Federal Bank Ltd 89 120 35.0 176,744 8.4 10.2 33.3 22.5 1.3 1.2 11.9 13.3
GAIL India Ltd 126 175 38.8 568,503 13.5 14.8 (3.2) 9.9 9.3 8.5 13.3 13.5
Source: Kotak PCG & KIE* (Kotak Institutional Equities); # Federal Bank are valued on PBV or Price/BV while rest of the stocks are valued on PE.; Source: KIE India Daily dated 29
Nov’19 and Stock Reco report of Kotak PCG dated 29 Nov’19.
Kotak Securities – Private Client Group Please see the Disclosure/Disclaimer on the last page For Private Circulation 3
Market Strategy
December 2019
INTERNATIONAL MARKETS
US and China agree to tentative truce on trade war
President Donald Trump heralded a breakthrough in U.S.-China trade talks, and markets rallied
in relief over a de-escalation in tensions and economy-damaging tariffs between the world's
two biggest economies. US has agreed (tweeted by President Trump) to suspend a tariff hike
on $250 billion from worth of Chinese imports. US President Trump also tweeted that, in
response the Chinese have agreed to buy $40 billion to $50 billion in U.S. farm products. But
nothing is in media.
As per media reports (NY times and Washington Post), U.S. and China are working to sign a
tentative trade war truce. But nothing's on paper and details are scarce about whether the end
to the 15-month trade war is in sight. It is unclear whether Trump will give any sort of deadline
for the talks to reach an agreement. Infact, NY times and Washington Post reported that the
U.S. is still scheduled to target another $160 billion of Chinese imports into US on 15 Dec.
2019, a move that would extend Trump's tariffs to virtually everything China ships to the United
States.
The two countries are deadlocked primarily over U.S. allegations by Trump on twitter, that
China deploys predatory tactics including outright theft—to become the global leader in
robotics, self-driving cars and other advanced technology. China has been reluctant to make
the kind of substantive policy reforms that would satisfy the Trump administration. Doing so
would likely require scaling back China's aspirations for technological supremacy, which China
sees as crucial to its prosperity.
Recently, the U.S. House of Representatives passed a bill intended to support protesters in
Hong Kong which prompted China to accuse the U.S. of interfering in domestic affairs.
The above discussion underscores the complexity of US/China negotiations, consistent with
our ongoing view that, over the medium term, there does not appear a reliable path to bridging
core trade differences that would lead to meaningful tariff de-escalation.
Kotak Securities – Private Client Group Please see the Disclosure/Disclaimer on the last page For Private Circulation 4
Market Strategy
December 2019
UK GDP had shrank 0.2% in the second quarter of and a further contraction in third quarter
would have meant a recession and dealt a major blow to Mr. Johnson’s hopes of securing a
victory in next month’s general election.
1.5
1
0.5
0
-0.5
-1
-1.5
-2
-2.5
Sep-06
Sep-07
Sep-08
Sep-09
Sep-10
Sep-11
Sep-12
Sep-13
Sep-14
Sep-15
Sep-16
Sep-17
Sep-18
Sep-19
Mar-06
Mar-07
Mar-08
Mar-09
Mar-10
Mar-11
Mar-12
Mar-13
Mar-14
Mar-15
Mar-16
Mar-17
Mar-18
Mar-19
Source: Bloomberg dated 28 November 2019
UK Elections
The UK election will take place on 12th December, 2019 making it the first winter poll since
1923.MPs backed the pre-Christmas election by 438 votes to 20, having rejected it three times
previously, after Boris Johnson agreed to ask the European Union (EU) for a fresh Brexit delay.
The incumbent Prime Minister Boris Johnson has given commitment in UK parliament to take
the UK out of the EU at any cost. Opinion polls so far show the Conservative Party in the lead.
Newly elected ECB President Christine Lagarde will chair the ECB meet on 12th December,
where she is expected to call for a coordinated approach to fiscal and monetary policy
amongst member countries.
Kotak Securities – Private Client Group Please see the Disclosure/Disclaimer on the last page For Private Circulation 5
Market Strategy
December 2019
1.0
0.8
0.6
0.4
0.2
0.0
May-15
Sep-15
May-16
Sep-16
May-17
Sep-17
May-18
Sep-18
Nov-18
May-19
Sep-19
Mar-15
Nov-15
Mar-16
Nov-16
Nov-17
Mar-19
Jan-16
Jan-17
Mar-17
Mar-18
Jan-18
Jan-19
Jul-15
Jul-16
Jul-17
Jul-18
Jul-19
Source: Bloomberg dated 28 November 2019
U.S. crude stocks swelled by 1.6 million barrels as on November 28th data as production hit a
record high at 12.9 million barrels per day. That countered optimism that a U.S.-China trade
deal was drawing closer, which may support stronger economic growth and fuel crude demand
and prices. Next week’s meeting of the Organization of the Petroleum Exporting Countries
(OPEC) and allies including Russia will be important as the group has been withholding output
to support prices.
Brent crude has corrected by 9.3% in the last 6 months. KIE estimates crude to average USD70
per barrel in CY19 and USD65 per barrel in CY20.
Kotak Securities – Private Client Group Please see the Disclosure/Disclaimer on the last page For Private Circulation 6
Market Strategy
December 2019
Currency market
Persistent US dollar (USD) strength, trade frictions, slowing global growth trends and Brexit
uncertainty will likely shape the direction of major currencies in the final quarter of the year
(and possibly beyond). The USD has fared better than expectation in CY19 and remains
resilient amid softer US yields and signs that the US economy is losing momentum. Going
forward, global slowdown trade war, Brexit, and other geo-political uncertainties will increase
the USD’s safe haven status and lift investor demand for the currency. We expect a more
gradual depreciation in the INR versus USD in FY20 versus the steep depreciation seen in
FY19; we model INR-USD rate at INR 71.1/US$ for FY20 versus INR 69.9/US$ in FY19 and INR
64.5/US$ in FY18.
USD to INR
75.0
70.0
65.0
60.0
55.0
May-14
Sep-14
May-15
Sep-15
May-16
Sep-16
May-17
Sep-17
May-18
Sep-18
May-19
Sep-19
Mar-14
Mar-15
Mar-16
Mar-17
Mar-18
Mar-19
Jan-14
Jul-14
Nov-14
Jan-15
Jul-15
Nov-15
Nov-16
Jan-16
Jul-16
Jan-17
Jul-17
Nov-17
Jan-18
Jul-18
Nov-18
Jan-19
Jul-19
Nov-19
Kotak Securities – Private Client Group Please see the Disclosure/Disclaimer on the last page For Private Circulation 7
Market Strategy
December 2019
1,500
1,400
1,300
1,200
1,100
1,000
Sep-14
Sep-15
Sep-16
Sep-17
Sep-18
Sep-19
May-14
May-15
May-16
May-17
May-18
May-19
Mar-14
Mar-15
Mar-16
Mar-17
Mar-18
Mar-19
Jan-14
Nov-14
Jan-15
Jul-15
Nov-15
Jan-16
Nov-16
Jan-17
Nov-17
Jan-18
Jul-18
Nov-18
Jan-19
Nov-19
Jul-14
Jul-16
Jul-17
Jul-19
Source: Bloomberg dated 28 November 2019
Kotak Securities – Private Client Group Please see the Disclosure/Disclaimer on the last page For Private Circulation 8
Market Strategy
December 2019
DOMESTIC MARKETS
Indian market is currently facing rich valuations which is at odds with the weak state of the
economy and so is the large price-value gap for both ‘growth’ and ‘value’ stocks. The market
and ‘quality’ part of the market are largely factoring in a reasonable recovery in the economy
and earnings. We remain skeptical about any quick recovery in the economy given structural
challenges. Earnings will recover faster due to (1) corporate tax cut and (2) lower loan-loss
provisions for banks.
The table below compares 2QFY20 PBT of Nifty stocks with 2QFY19, 1QFY20 and 2QFY20E
PBT. Among Nifty-50 Index stocks that significantly outperformed our estimates at the PBT
level were (1) Cipla (led by growth in domestic business), (2) Dr Reddy’s (boosted by one-time
licensing income), (3) Maruti Suzuki (cost reduction, better-than-expected other income), (4)
NTPC (surcharge income of Rs6.5 bn boosted earnings) and (5) Tata Motors (strong JLR
performance).
Kotak Securities – Private Client Group Please see the Disclosure/Disclaimer on the last page For Private Circulation 9
Market Strategy
December 2019
Bajaj Auto Automobiles & Components 16.5 15.8 16.1 16.1 0.0 (3.0) 2.0
Eicher Motors Automobiles & Components 7.4 7.1 6.0 6.3 (5.0) (19.0) (15.0)
Hero Motocorp Automobiles & Components 14.5 11.4 11.0 10.0 9.0 (24.0) (3.0)
Mahindra & Mahindra Automobiles & Components 21.6 13.7 17.6 16.9 4.0 (19.0) 28.0
Maruti Suzuki Automobiles & Components 32.1 19.1 15.7 11.9 32.0 (51.0) (18.0)
Tata Motors Automobiles & Components 2.1 (29.9) 7.0 (3.6) 292.0 238.0 123.0
Axis Bank Banks 11.7 20.8 24.3 34.1 (29.0) 109.0 17.0
HDFC Bank Banks 76.6 85.3 90.0 75.3 19.0 17.0 5.0
ICICI Bank Banks 12.6 27.9 43.7 41.0 6.0 248.0 56.0
IndusInd Bank Banks 14.0 21.6 18.6 17.1 9.0 33.0 (14.0)
Kotak Mahindra Bank Banks 25.5 29.1 29.4 33.1 (11.0) 15.0 1.0
State Bank of India Banks 18.1 40.6 50.6 43.3 17.0 179.0 25.0
YES Bank Banks 14.3 1.7 1.2 (13.2) 109.0 (91.0) (30.0)
Bajaj Finance Diversified Financials 14.3 18.5 20.2 18.8 8.0 41.0 9.0
Bajaj Finserv Diversified Financials 18.1 22.6 26.3 25.9 1.0 45.0 16.0
HDFC Diversified Financials 34.9 39.9 45.3 46.9 (3.0) 30.0 14.0
L&T Capital Goods 28.5 26.6 33.0 34.4 (4.0) 16.0 24.0
Asian Paints Commodity Chemicals 7.4 10.1 8.4 9.9 (16.0) 13.0 (17.0)
Grasim Industries Construction Materials 11.1 6.5 6.5 9.2 (29.0) (41.0) 1.0
UltraTech Cement Construction Materials 5.4 18.9 9.5 13.6 (30.0) 77.0 (50.0)
Britannia Industries Consumer Staples 4.6 4.1 5.0 4.6 9.0 9.0 23.0
Hindustan Unilever Consumer Staples 21.9 25.6 23.6 25.6 (8.0) 8.0 (8.0)
ITC Consumer Staples 43.7 48.1 48.1 47.5 1.0 10.0 0.0
Nestle India Consumer Staples 6.9 6.7 7.1 7.4 (5.0) 3.0 6.0
NTPC Electric Utilities 30.0 36.7 43.7 33.5 30.0 45.0 19.0
Power Grid Electric Utilities 29.3 33.0 32.8 32.6 1.0 12.0 0.0
UPL Fertilizers & Agricultural Chemicals 4.6 3.0 4.8 7.9 (39.0) 5.0 59.0
GAIL (India) Gas Utilities 28.7 19.8 17.2 19.0 (9.0) (40.0) (13.0)
HCL Technologies IT Services 32.0 29.3 34.9 33.0 6.0 9.0 19.0
Infosys IT Services 56.3 51.7 55.0 53.6 2.0 (2.0) 6.0
TCS IT Services 103.6 106.4 105.3 110.6 (5.0) 2.0 (1.0)
Tech Mahindra IT Services 14.6 12.9 13.4 12.3 9.0 (8.0) 4.0
Wipro IT Services 24.2 30.7 31.3 30.4 3.0 30.0 2.0
Zee Entertainment Ent Media 6.5 7.4 6.8 6.1 11.0 4.0 (9.0)
Hindalco Industries Metals & Mining 4.7 0.6 1.4 1.0 40.0 (71.0) 139.0
JSW Steel Metals & Mining 30.3 17.9 2.0 6.8 (70.0) (93.0) (89.0)
Tata Steel Metals & Mining 52.1 15.7 (2.1) 1.9 (212.0) (104.0) (113.0)
Vedanta Metals & Mining 23.0 20.8 15.4 18.5 (16.0) (33.0) (26.0)
BPCL Oil, Gas & Consumable Fuels 18.7 13.5 16.6 18.1 (9.0) (12.0) 22.0
Coal India Oil, Gas & Consumable Fuels 51.2 70.1 42.8 35.5 21.0 (16.0) (39.0)
IOCL Oil, Gas & Consumable Fuels 49.2 47.5 8.1 33.8 (76.0) (83.0) (83.0)
ONGC Oil, Gas & Consumable Fuels 127.1 90.6 90.4 84.2 7.0 (29.0) 0.0
Reliance Industries Oil, Gas & Consumable Fuels 132.0 143.4 150.0 149.2 1.0 14.0 5.0
Cipla Pharmaceuticals 5.1 6.6 6.8 5.7 19.0 34.0 3.0
Dr Reddy's Laboratories Pharmaceuticals 5.9 4.9 7.5 5.5 37.0 29.0 55.0
Sun Pharmaceuticals Pharmaceuticals 13.3 16.5 14.2 14.5 (1.0) 7.0 (14.0)
Titan Company Retailing 4.7 5.2 4.3 5.2 (18.0) (10.0) (18.0)
Bharti Airtel Telecommunication Services (20.2) (16.3) (9.4) (15.5) 39.0 53.0 42.0
Bharti Infratel Telecommunication Services 10.2 9.4 8.8 9.7 (10.0) (14.0) (6.0)
Adani Ports and SEZ Transportation 13.2 14.0 13.2 14.6 (9.0) 0.0 (5.0)
Nifty-50 Index 1314.0 1283.0 1279.0 1260.0 1.5 (2.6) (0.3)
Source: Bloomberg, Companies, Kotak Institutional Equities estimates
Kotak Securities – Private Client Group Please see the Disclosure/Disclaimer on the last page For Private Circulation 10
Market Strategy
December 2019
April 3.0 3.8 5.1 2.9 4.9 4.0 5.4 2.1 6.0 3.2 4.5 4.3
May 0.3 5.8 3.2 2.6 3.6 2.5 8.3 4.2 7.4 2.9 3.8 3.1
June 0.1 6.5 1.5 (0.7) 6.9 0.2 2.1 8.5 8.2 (0.3) 7.0 1.2
July 4.5 3.4 4.9 (0.1) 7.0 4.2 6.6 6.6 4.8 1.0 6.5 4.3
August 9.3 (0.6) 0.0 3.8 5.2 (1.6) 8.3 7.6 (0.9) 4.8 4.8 (1.4)
September 7.6 0.1 (8.5) 3.8 4.8 (3.9) 3.4 8.2 (2.6) 4.1 4.1 (4.3)
October (0.2) 7.3 2.0 8.2 3.2 10.8 1.8 1.8
November 1.4 2.7 10.4 (0.7) 3.9 5.1 8.5 8.5
December 1.2 (1.0) 8.7 2.9 4.4 4.5 7.3 7.3
January 0.3 3.8 8.7 1.3 7.6 0.9 7.5 7.5
February (0.4) 2.2 8.4 (0.3) 4.5 1.3 6.9 6.9
March 3.1 0.8 5.7 0.1 5.9 2.2 5.3 5.3
Average 2.5 2.9 4.7 3.7 5.3 5.2 4.4 4.4
Source: CEIC, Kotak Institutional Equities
Revise down our FY20 GDP growth estimate further by 30 bps to 4.7%
While favorable base effects, increased pace of government spending, lower short-term rates
due to lower policy rates and easier liquidity conditions could provide some support to growth
in 2HFY20, we see limited room for a meaningful revival in activity in the months ahead. The
government’s fiscal space to support economic activity is limited after the corporate tax rate
cuts and GST shortfall. High frequency data for October/November suggest that economic
activity weakened further despite festive season demand. With the growth slowdown
remaining entrenched, we further revise down our FY20 GDP estimate by 30 bps to 4.7%.On
the policy front, we expect the MPC to look through the impact of higher food prices after a
dismal 1HFY20 growth and take cues from the moderating core inflation. The MPC will have
to revise down the FY20 GDP estimate from 6.1% while revising higher the near-term CPI
inflation trajectory. We reiterate our call of another 50 bps of repo rate cuts through the rest of
FY20. Beyond that, the MPC will likely stay on hold and focus on transmission as the GDP
growth gradually reverses to 5.5-6.0% and inflation hovers slightly above the 4% mark.
Kotak Securities – Private Client Group Please see the Disclosure/Disclaimer on the last page For Private Circulation 11
Market Strategy
December 2019
12
CPI (%) WPI (%)
9
6 4.6%
3
0 2.0%
-3
-6
-9
Sep-13
Sep-14
Sep-15
Sep-16
Sep-17
Sep-18
Sep-19
Mar-14
Mar-15
Mar-16
Mar-17
Mar-18
Mar-19
Mar-20
Dec-13
Jun-13
Jun-14
Dec-14
Jun-15
Dec-15
Jun-16
Dec-16
Jun-17
Dec-17
Jun-18
Dec-18
Jun-19
Dec-19
Risks to our base case of a 50 bps rate cut through the rest of FY20
CPI and WPI inflations both were largely led by higher food inflation, even as core inflation
remains muted. With CPI inflation likely to overshoot the MPC’s target of 4% by around 75-125
bps over the next few months, we believe that the policy decision will be split among the MPC
members given that inflation is trending above 4.7% and growth is likely to be below 5% in
2QFY20. If the MPC members believe that the recent increase in food inflation is transient and
assign higher weightage to the moderating core inflation, they may continue to focus on
reviving growth and look through the recent and upcoming inflation readings. MPC members’
perception about ‘flexible inflation targets’ will be tested in the December policy. We believe
that maintaining accommodative financial conditions in the current subdued environment is
essential, which will likely prompt the MPC to cut rates. While we continue to see room for
Kotak Securities – Private Client Group Please see the Disclosure/Disclaimer on the last page For Private Circulation 12
Market Strategy
December 2019
monetary easing amid weakening growth, a higher inflation trajectory poses risks to our base
case of 50 bps of rate cuts.
After accounting for higher divestment of around Rs1.3 TN in FY20, 23% higher than budgeted
target of Rs1.05 tn, part of the tax shortfall will also be met through excess RBI dividend and
likely higher dividend receipts from PSUs. Without any expenditure cuts, there is likely to be a
GFD/GDP slippage of 0.4-0.5% increasing the risks of higher borrowings (possibly in January-
February).However, if the government was to choose to stick to budgeted GFD/GDP, it may
rely on expenditure reductions in food subsidy, agriculture and farmers’ welfare (PM-KISAN)
and other smaller expenditure heads while possibly allocating a higher expenditure to rural
development (NREGA, etc.) to balance between restricting the extent of fiscal slippage and
supporting growth through government spending.
Kotak Securities – Private Client Group Please see the Disclosure/Disclaimer on the last page For Private Circulation 13
Market Strategy
December 2019
Escalating trade tensions and a slowing global economy have prompted the World Trade
Organization to sharply downgrade its trade growth forecast for 2019 to 1.2% (from 2.6%) and
2020 to 2.7% (from 3%).
Cement production 8.8 11.6 11.0 8.0 15.7 2.3 2.8 (1.7) 7.9 (4.9) (2.1) (7.7)
Commerical vehicle sale 5.7 (7.8) 2.2 (0.4) 0.3 (6.0) (10.0) (12.3) (25.7) (38.7) (39.1) (23.3)
IIP Manufacturing (0.7) 2.9 1.3 (0.3) 3.1 2.5 4.4 0.3 4.5 (1.6) (3.9)
Rail freight traffic 5.6 2.7 5.5 4.4 7.2 1.9 0.7 0.0 (1.3) (8.7) (11.2) (11.1)
Steel production 3.7 6.6 1.6 3.7 3.7 0.4 3.3 5.6 3.4 3.5 1.6 (1.6)
Airport passenger traffic 11.0 12.9 8.9 5.6 0.1 (4.4) 2.8 6.2 1.8 3.9 1.1 3.1
Passenger Vehicle sales (3.4) (0.4) (1.9) (1.1) (3.0) (17.1) (20.5) (17.5) (31.0) (31.6) (23.7) 0.3
Two wheeler sales 7.1 (2.2) (5.2) (4.2) (17.3) (16.4) (6.7) (11.7) (16.8) (22.2) (22.1) (14.4)
Source: CEIC, Kotak Institutional Equities
Kotak Securities – Private Client Group Please see the Disclosure/Disclaimer on the last page For Private Circulation 14
Market Strategy
December 2019
(1) Fiscal stimulus may not be possible given the high fiscal deficit; high fiscal deficit rules out
a meaningful fiscal stimulus, especially as (1) tax revenues have been largely stagnant and (2)
the government cut the corporate tax rate in September 2019. We expect FY20 central
GFD/GDP to slip by 50-60 bps versus the target of 3.3%.
(2) Monetary policy has been rendered ineffective by government borrowing. The Indian
economy has seen limited benefits of the rate cuts by the RBI. The RBI has cut repo rates by
135 bps in CYTD19, but banks have reduced MCLR by about 55 bps. Bond yields have declined
meaningfully but they are less relevant for the economy. Bank rates are more relevant as a
bulk of India’s borrowing and lending is through the banking system. The government
competes with banks for deposits as it is a big borrower through the small savings scheme
funds route. Nonetheless, banks have finally started to reduce term-deposit rates, given the
high liquidity in the banking system, which should bode well for lower interest rates over the
next few quarters.
(3) Structural reforms may not be easy to implement and will, in any case, take time to show up
in higher investment and GDP growth. In our view, the government may have to implement
major reforms in (1) the factors of production to increase investment in manufacturing and (2)
the ownership and pricing policies to increase private sector investment in infrastructure. The
government did reduce the corporate tax rate in September 2019, which would suggest that
the government is keen to increase India’s investment rate. It has steadfastly worked to
improve India’s position in global ‘ease of doing business’ indices.
The government is unable to maximize the value of its CPSE ownership due to low valuations
of PSU companies (de-rating of multiples of PSUs over the past few years), further accentuated
by sale through ETFs. We believe the government can raise significantly higher amounts if it
were to privatize the PSUs through (1) strategic sale of majority stake or (2) sale of its shares
in tranches to institutional and retail investors with an explicit commitment to reduce its
holding to below 50%. We would strongly argue against golden share or any form of residual
government control as it would lead to valid concerns about continued government influence
on the operations of the companies.
Kotak Securities – Private Client Group Please see the Disclosure/Disclaimer on the last page For Private Circulation 15
Market Strategy
December 2019
Government has set an aggressive enhanced target of Rs 1.05 trillion of disinvestment receipts
in Budget FY20. As part of its disinvestment or privatization strategy, the Union Cabinet on 20th
November gave approval to sell majority stake in BPCL, Concor and SCI before the end of FY20.
We believe, privatization will generate non-tax revenue and help government keep fiscal deficit
in check projected at 3.3% of GDP. Privatization is not a piecemeal sale of minority stake but
a full transfer of control. To help the privatization drive, government may lift restrictions on
foreign ownership and other onerous conditions. This will complement the current effort in
reviving investment.
Kotak Securities – Private Client Group Please see the Disclosure/Disclaimer on the last page For Private Circulation 16
Market Strategy
December 2019
The winter session will have 20 sittings between November 18 and December 13, and is
expected to discuss 27 new bills.
The Taxation Laws (Amendment) Bill, 2019 Prohibition of Electronic Cigarettes Bill 2019
The Companies (Second Amendment) Bill, 2019 The National Commission for Indian System of Medicine
Bill, 2019
Chit Funds (Amendment) Bill, 2019 The Transgender Persons (Protection of Rights) Bill, 2019
The Industrial Relations Code Bill, 2019 The Personal Data Protection Bill
Competition Amendment Bill 2019 Citizenship (Amendment) Bill
Insolvency and Bankruptcy (2nd Amendment) Bill 2019 Personal Data Protection Bill.
Surrogacy (Regulation) Bill, 2019
Source: PRS Legislative Research
Kotak Securities – Private Client Group Please see the Disclosure/Disclaimer on the last page For Private Circulation 17
Market Strategy
December 2019
Politics
By-polls in Karnataka on December 5th
The Supreme Court on 13th November upheld the disqualification of the 17 Karnataka MLAs
on the orders of the then Assembly Speaker KR Ramesh Kumar but allowed them to contest
the by-elections to be held on December 5 for 15 seat that fell vacant in July, 2019.
The judgment is a big boost for the BS Yediyurappa BJP government in the state as the MLAs
— fourteen from the Congress and three from the JD-S — were hopeful of being given tickets
by the BJP to contest the by-elections to 15 seats.
Kotak Securities – Private Client Group Please see the Disclosure/Disclaimer on the last page For Private Circulation 18
Market Strategy
December 2019
SECTORAL SNIPPETS
Automobiles
We expect net profits of the automobiles sector to decline 15% in FY20 due to sharp decline in
volumes, which in turn is due to extremely weak domestic demand conditions. However, we
expect a sharp bounce in net profits in FY21 entirely led by profits at Tata Motors (TTMT)
versus a loss in FY20 (and FY19). However, we do see risks to (1) domestic demand and
profitability, which will affect profits of the leading 2-W and 4-W companies and (2) global
demand, which may affect profits of TTMT although TTMT has made significant progress in
reducing costs on a structural basis to counter the ongoing global slowdown.
We assume (1) sharp decline in domestic volumes in FY20 despite our expectation of a
recovery in volumes in 2HFY20 due to pre-buying of vehicles before the implementation of BS-
VI fuel emission norms from April 1, 2020 and (2) moderate decline in gross and EBITDA
margins given higher costs related to implementation of new safety regulations (ABS/CBS
applicable from April 1, 2019 for 2-Ws and ABS applicable from July 1, 2019 for 4-Ws) and fuel
emission standards (BS-VI fuel standards applicable from April 1, 2020).
For the NBFCs, we see pressure on NIMs/RoEs in general due to (1) higher cash balance on
the balance sheet of NBFCs as they negotiate the current tight liquidity conditions, which may
persist through FY20, (2) increased share of low-risk, low-yield retail loans (mortgage) in the
case of HFCs at the expense of high-risk, high-yield developer loans, (3) potential increase in
credit costs, especially for HFCs and (4) more competition from banks in all the lending
segments. We have already seen a squeeze on the NIMs of the HFCs due to increased
competition in the housing finance segment.
Construction materials
We assume higher profitability for cement stocks under our coverage for FY20-22. We note
that realizations and profitability have increased sharply over the past 8-9 months. However,
we are not sure if prices will hold up as demand conditions have worsened significantly over
the past few months and capacity utilization will remain low for the sector on large supply-
demand imbalance through FY22.
Kotak Securities – Private Client Group Please see the Disclosure/Disclaimer on the last page For Private Circulation 19
Market Strategy
December 2019
Consumer products.
We expect the consumer product companies to deliver high single-digit/low double-digit
revenue growth in FY20 (lower than in previous years) led by (1) modest 3-5% volume growth
in most cases and (2) moderate increase in prices. However, we expect strong growth in net
profits (around 20%) in FY20 due to lower corporate tax rate. We note that demand conditions
have worsened significantly over the past quarter. However, a benign RM environment will
result in a further increase in margins, which have already jumped sharply in the past few years.
IT services
We expect net profit growth of IT stocks in the Nifty-50 Index to taper down to 3.8% in FY20
from 16% in FY19 as we expect (1) a more gradual depreciation in the INR versus USD in FY20
versus the steep depreciation seen in FY19; we model INR-USD rate at INR 71.1/US$ for FY20
versus INR 69.9/US$ in FY19 and INR 64.5/US$ in FY18, (2) decline in margins on higher costs
(higher share of on-shoring given industry and visa issues) and limited tailwind from currency
depreciation and (3) weaker demand from customers given worries about general slowdown
in global economic growth; FY19 revenues were also boosted by stronger demand from US
clients who increased spending on IT following tax cuts in CY18.
Pharmaceuticals
We expect 14% and 29% growth in the net profits of the pharmaceuticals sector in FY20 and
FY21 on the back of (1) pickup in new launches of generic products in the US from 2HFY19,
which will drive US generic revenues and overall, revenues and profits, (2) strong increase in
revenues of Sun’s specialty products, which would drive its overall revenues and (3) steady
growth in domestic pharmaceutical revenues. We expect US generic revenues to recover
sharply over FY20-21 on the back of new launches although the timing of the launches is still
somewhat uncertain, which may push back the recovery in revenues and profits.
Kotak Securities – Private Client Group Please see the Disclosure/Disclaimer on the last page For Private Circulation 20
Market Strategy
December 2019
9.0
. 7.0
Aug-11
Aug-12
Aug-13
Aug-14
Aug-15
Aug-16
Aug-17
Aug-18
Aug-19
May-08
May-09
May-10
May-11
May-12
May-13
May-14
May-15
May-16
May-17
May-18
May-19
Aug-07
Feb-08
Aug-08
Feb-09
Aug-09
Feb-10
Aug-10
Feb-11
Feb-12
Feb-13
Feb-14
Feb-15
Nov-15
Feb-16
Feb-17
Feb-18
Feb-19
Nov-07
Nov-08
Nov-09
Nov-10
Nov-11
Nov-12
Nov-13
Nov-14
Nov-16
Nov-17
Nov-18
Nov-19
Source: Bloomberg
10.0
5.0
Aug-07
Apr-08
Aug-08
Apr-09
Aug-09
Apr-10
Aug-10
Apr-11
Aug-11
Apr-12
Aug-12
Apr-13
Aug-13
Apr-14
Aug-14
Apr-15
Aug-15
Apr-16
Aug-16
Apr-17
Aug-17
Apr-18
Aug-18
Apr-19
Aug-19
Dec-12
Dec-15
Dec-11
Dec-13
Dec-14
Dec-16
Dec-17
Dec-18
Dec-19
Dec-07
Dec-08
Dec-09
Dec-10
Source: Bloomberg
30%
20%
10%
Dec-15
Dec-17
Dec-09
Jun-10
Dec-10
Jun-11
Dec-11
Jun-12
Dec-12
Jun-13
Dec-13
Jun-14
Dec-14
Jun-15
Jun-16
Dec-16
Jun-17
Jun-18
Dec-18
Jun-19
Dec-19
Source: Bloomberg
Kotak Securities – Private Client Group Please see the Disclosure/Disclaimer on the last page For Private Circulation 21
Market Strategy
December 2019
GAIL: BUY
CMP: Rs.126 Fair Value: Rs.175 Market Cap: Rs.569 bn
GAIL's management has indicated that (1) optimism on increase in LNG offtake by three
new fertilizer plants over the next six months, (2) on-track commissioning of the Kochi-
Mangalore pipeline by Dec'19, (3) annual capex guidance of Rs70 bn in FY20-21; Rs80 bn
has already been incurred on East India gas pipeline network and (4) the company may
move to lower tax rate regime later depending on utilization of MAT credit and other
considerations; KIE have assumed tax rates at lower levels of ~27% for now.
KIE expects GAIL to benefit from (1) inclusion of gas under GST, (2) turnaround in petchem
segment post recent full ramp-up in plant utilization and likely improvement in efficiencies
and margins, (3) medium-term growth in gas volumes amid rising availability and favorable
policies and (4) potential realignment of tariffs under a new regulatory framework such as
unification to allow reasonable returns on gas pipeline assets.
GAIL's adjusted net income declined 7% qoq to Rs11.9 bn (EPS of Rs. 2.6), boosted by
higher other income and lower tax rate. Adjusted EBITDA declined 23% qoq to Rs17.5 bn in
Q2FY20, led by (1) lower contribution from gas marketing and (2) decline in profits from
LPG/LHC segment amid lower prices, which was partly offset by a robust increase in gas
transmission EBITDA and volume-led improvement in petchem performance.
KIE expects standalone EPS of Rs13.5 in FY20, Rs14.8 in FY21 and Rs.15.9 in FY22
factoring in (1) lower contribution from gas marketing, LPG/LHC and petchem segments,
(2) modestly higher other income and (3) other minor changes. KIE's SoTP-based fair value
is Rs.175. KIE's reverse valuation exercise, adjusted for the MTM value of investments,
implies that the stock is trading at an attractive 6.6X FY21E corebusiness EPS providing
adequate margin of safety against earnings volatility.
Note: The above is brief note on the company, based on the research report and update
available (dated: 9th Nov’19) on our website at:
https://www.kotaksecurities.com/research_report/recommendation/indiadaily.html
Kotak Securities – Private Client Group Please see the Disclosure/Disclaimer on the last page For Private Circulation 22
Market Strategy
December 2019
FIEM's product portfolio comprises of automotive lighting, rear view mirrors, sheet metal
parts and plastic components for two /four wheeler segment. FIEM generates ~98% of its
revenues from the automotive business and balance revenue comes from the IPIS & LED
luminaries segment. Within the automotive space, FIEM is largely an OEM focused
company with ~93% of revenues coming from domestic OEM's and two wheeler segment
accounts for ~96% of automotive revenues. For FIEM, Honda Motorcycle and Scooters
India Limited (HMSI) and TVS Motors (TVSM) are the top clients.
2QFY20 result - FIEM reported revenue of Rs3.71bn, 6% YoY decline. EBITDA margin
improved YoY by 100bps to 11.1%, supported by gross margin expansion. Company
reported PAT of Rs156mn, 6% higher over 2QFY19.
FIEM continues to outperform two wheeler industry on the back of market share gain with
few clients. We expect the transition from halogen to LED will continue over the medium to
longer term; however given steep increase in two wheeler cost to end customer and general
slowdown in demand, we expect the process to be slow in the near term. FIEM will be
starting production at bank angle sensor plant in 4QFY20. Company expects revenue of
Rs500-600mn in FY21 from this product.
In the past four quarters, the company’s EBITDA margin has sustained above 11% and the
company aims to improve it further to 11.5%-12% going ahead.
We retain BUY on the stock with revised price target of Rs549 (earlier Rs523), valuing the
stock at a PE of 10x on FY21E earnings.
Note: The above is brief note on the company, based on the research reports dated 18th
Nov’19 and available on our website at:
https://www.kotaksecurities.com/ksweb/ResearchCall/Fundamental
Kotak Securities – Private Client Group Please see the Disclosure/Disclaimer on the last page For Private Circulation 23
Market Strategy
December 2019
Escorts is well-positioned to benefit from a normal monsoon, higher reservoir levels and
improving MSPs for rabi crop in the near term. KIE believe Escorts is well-placed to benefit
from the structural tractor demand potential in India. Strong growth in the railway business
will also support margins of the company.
2QFY20 result - Net revenues declined by 5% yoy to Rs13.2 bn. The revenue decline was
due to (1) 5% yoy decline in tractor revenues and (2) 19% yoy decline in construction
revenues, which was partially offset by 20% yoy growth in railway segment revenues in
2QFY20. Escorts reported 2QFY20 EBITDA of Rs1.27 bn (-20% yoy) and net profit of Rs1.05
bn (+2% yoy). Tractor EBIT margin came in at 10.3% (down 440 bps yoy).
The company highlighted that the domestic tractor industry may decline by 5% yoy in
FY2020E, which implies flattish yoy growth in 2HFY20. Domestic tractor industry volumes
were down by 10% yoy in 2QFY20. Escorts’ market share was marginally up yoy at 11.2% in
2QFY20.
In the construction equipment segment, the company expects to achieve 4% EBIT margin
in FY2020 and 7-8% EBIT margin in this division over the next two-three years. Railways
segment has an order book of Rs5 bn as of September 30, 2019. The company expects the
railway division to grow by 15-20% yoy in FY2020.
KIE maintains BUY rating on the stock with fair value of Rs1,030, valuing the stock at15X
Sep 2021E EPS.
Note: The above is brief note on the company, based on the research report and update
available (dated: 4th Nov’19) on our website at:
https://www.kotaksecurities.com/research_report/recommendation/indiadaily.html
Kotak Securities – Private Client Group Please see the Disclosure/Disclaimer on the last page For Private Circulation 24
Market Strategy
December 2019
After a few disappointing quarters, JYL reported a healthy print with 8.5% revenue growth,
solid in the context of a broader slowdown. In Q2FY20, the fabric care portfolio grew 13.1%
yoy, Dishwash segment grew 8.6% yoy and Personal care segment reported a 6.9% yoy
growth.
Management continues to guide for 10-12% revenue growth for the year, hinging on a big
recovery in the HI segment in the next two quarters.
The RM environment continues to be fairly benign, which should help see stable margins.
We fine-tune our model – some topline weakness is offset by some cut in ad-spends. Retain
ADD with a TP of Rs 200; believe JYL’s portfolio has the potential to deliver.
Note: The above is brief note on the company, based on the research report and update
available (dated: 22nd Oct’19) on our website at:
https://www.kotaksecurities.com/research_report/recommendation/indiadaily.html
Kotak Securities – Private Client Group Please see the Disclosure/Disclaimer on the last page For Private Circulation 25
Market Strategy
December 2019
In Iine quarter; US continues to drag while domestic drives the growth; ADD with upward
revised fair value of Rs 480.
Sun Pharma reported sales of Rs 81.2 Bn, 17% YoY growth driven by domestic business;
EBIDTA stood at Rs 17.8 Bn, 16.3% YoY growth; EBIDTA margins were 21.9%; Profit for the
quarter was Rs 10.6 Bn. Gross margins at 72.1% were 110 bps higher than KIE estimates,
given the geographical mix.
Global Speciality sales for the quarter stood at $90 mn bulk of which are from Absorica and
Levulan; KIE expects Ilumya to reach US$145 mn sales in FY21, and further increase to
US$177 mn in FY22; Cequa is likely to contribute from 4QFY20.
US ex-Taro sales unexpectedly declined US$85 mn qoq to US$339 mn, as against KIE
estimates of US$390 mn, with the management attributing it largely to the loss of a one-
time supply contract. RoW and EM sales were largely in line with KIE estimates.
KIE believes that the market concerns on the specialty pipeline are now adequately
captured in the current valuation. with upward revised Fair Value of Rs 480/share
Note: The above is brief note on the company, based on the research report and update
available (dated: 7th Nov’19) on our website at:
https://www.kotaksecurities.com/research_report/recommendation/indiadaily.html
Kotak Securities – Private Client Group Please see the Disclosure/Disclaimer on the last page For Private Circulation 26
Market Strategy
December 2019
Federal Bank reported 57% YoY growth in Q2FY20 earnings majorly due to lower income
tax provisions (down ~65% YoY). Pretax profit was up 15% yoy in Q2FY20
Bank reported ~15% YoY loan growth (down from ~20% in earlier quarters). Growth in retail
lending (25% YoY) and agricultural loans (20% YoY) was robust but there was weakness in
corporate loans (~8% growth from 30-40% range until 9MFY19).
Overall deposit growth and CASA growth were strong at 18% YoY and 13% YoY respectively.
This resulted in 10bps increased in CASA ratio to ~32%.
Gross NPL and Net NPL increased 6% and 10% QoQ to Rs. 36.1 bn and Rs. 18.4 bn
respectively. Gross NPLs and Net NPLs stood at 3.1% and 1.6%, respectively at the end of
Q2FY20. Slippages were higher at Rs. 5.4 bn (1.9% of loans). Bank has ~ 15% exposure to
HFCs and NBFC. 98% of HFC exposure and 97% of NBFC exposure are ‘A’ rated and above.
KIE forecasts: loans to grow at ~15% CAGR over FY19-20E. NIM to marginally increase by
10bps over FY19-22E to 2.8%. Gross NPL to remain broadly stable at around 3% levels until
FY22E. CASA ratio to remain in the range of ~32-33% driven by 15% CASA CAGR over FY19-
22E
KIE maintains its BUY rating on the stock with fair value of Rs. 120 (from Rs. 130) valuing
the bank at ~1.7X book and 13X September 2021E EPS for RoEs in the range of ~14% in
the medium term and strong earnings growth of ~25% CAGR in FY19-22E.
Note: The above is brief note on the company, based on the research report and update
available (dated: 16th Oct’19) on our website at:
https://www.kotaksecurities.com/research_report/recommendation/indiadaily.html
Kotak Securities – Private Client Group Please see the Disclosure/Disclaimer on the last page For Private Circulation 27
RATING SCALE (KOTAK SECURITIES – PRIVATE CLIENT GROUP) / KOTAK INSTITUTIONAL EQUITIES
Definitions of ratings
BUY – We expect the stock to deliver more than 15% returns over the next 12 months
ADD – We expect the stock to deliver 5% - 15% returns over the next 12 months
REDUCE – We expect the stock to deliver -5% - +5% returns over the next 12 months
SELL – We expect the stock to deliver < -5% returns over the next 12 months
NR – Not Rated. Kotak Securities is not assigning any rating or price target to the stock. The report has been prepared for
information purposes only.
SUBSCRIBE – We advise investor to subscribe to the IPO.
RS – Rating Suspended. Kotak Securities has suspended the investment rating and price target for this stock, either because there
is not a Sufficient fundamental basis for determining, or there are legal, regulatory or policy constraints around publishing,
an investment rating or target. The previous investment rating and price target, if any, are no longer in effect for this stock
and should not be relied upon.
NA – Not Available or Not Applicable. The information is not available for display or is not applicable
NM – Not Meaningful. The information is not meaningful and is therefore excluded.
NOTE – Our target prices are with a 12-month perspective. Returns stated in the rating scale are our internal benchmark.
Kotak Securities – Private Client Group Please see the Disclosure/Disclaimer on the last page For Private Circulation 28
Disclosure/Disclaimer (Private Client Group)
Kotak Securities Limited established in 1994, is a subsidiary of Kotak Mahindra Bank Limited. Kotak Securities is one of India's largest brokerage and distribution house.
Kotak Securities Limited is a corporate trading and clearing member of BSE Limited (BSE), National Stock Exchange of India Limited (NSE), Metropolitan Stock Exchange
of India Limited (MSE), National Commodity and Derivatives Exchange (NCDEX) and Multi Commodity Exchange (MCX). Our businesses include stock broking, services
rendered in connection with distribution of primary market issues and financial products like mutual funds and fixed deposits, depository services and Portfolio
Management.
Kotak Securities Limited is also a depository participant with National Securities Depository Limited (NSDL) and Central Depository Services (India) Limited (CDSL).
Kotak Securities Limited is also registered with Insurance Regulatory and Development Authority as Corporate Agent for Kotak Mahindra Old Mutual Life Insurance
Limited and is also a Mutual Fund Advisor registered with Association of Mutual Funds in India (AMFI). We are registered as a Research Analyst under SEBI (Research
Analyst) Regulations, 2014.
We hereby declare that our activities were neither suspended nor we have defaulted with any stock exchange authority with whom we are registered in last five years.
However SEBI, Exchanges and Depositories have conducted the routine inspection and based on their observations have issued advise/warning/deficiency letters/ or
levied minor penalty on KSL for certain operational deviations. We have not been debarred from doing business by any Stock Exchange / SEBI or any other authorities;
nor has our certificate of registration been cancelled by SEBI at any point of time.
We offer our research services to clients as well as our prospects.
This document is not for public distribution and has been furnished to you solely for your information and must not be reproduced or redistributed to any other person.
Persons into whose possession this document may come are required to observe these restrictions.
This material is for the personal information of the authorized recipient, and we are not soliciting any action based upon it. This report is not to be construed as an offer
to sell or the solicitation of an offer to buy any security in any jurisdiction where such an offer or solicitation would be illegal. It is for the general information of clients
of Kotak Securities Ltd. It does not constitute a personal recommendation or take into account the particular investment objectives, financial situations, or needs of
individual clients.
We have reviewed the report, and in so far as it includes current or historical information, it is believed to be reliable though its accuracy or completeness cannot be
guaranteed. Neither Kotak Securities Limited, nor any person connected with it, accepts any liability arising from the use of this document. The recipients of this material
should rely on their own investigations and take their own professional advice. Price and value of the investments referred to in this material may go up or down. Past
performance is not a guide for future performance. Certain transactions -including those involving futures, options and other derivatives as well as non-investment
grade securities - involve substantial risk and are not suitable for all investors. Reports based on technical analysis centers on studying charts of a stock's price
movement and trading volume, as opposed to focusing on a company's fundamentals and as such, may not match with a report on a company's fundamentals.
Opinions expressed are our current opinions as of the date appearing on this material only. While we endeavor to update on a reasonable basis the information discussed
in this material, there may be regulatory, compliance or other reasons that prevent us from doing so. Prospective investors and others are cautioned that any forward-
looking statements are not predictions and may be subject to change without notice. Our proprietary trading and investment businesses may make investment
decisions that are inconsistent with the recommendations expressed herein.
Kotak Securities Limited has two independent equity research groups: Institutional Equities and Private Client Group. This report has been prepared by the Private Client
Group.
We and our affiliates/associates, officers, directors, and employees, Research Analyst(including relatives) worldwide may: (a) from time to time, have long or short
positions in, and buy or sell the securities thereof, of company (ies) mentioned herein or (b) be engaged in any other transaction involving such securities and earn
brokerage or other compensation or act as a market maker in the financial instruments of the subject company/company (ies) discussed herein or act as advisor or
lender / borrower to such company (ies) or have other potential/material conflict of interest with respect to any recommendation and related information and opinions
at the time of publication of Research Report or at the time of public appearance. Kotak Securities Limited (KSL) may have proprietary long/short position in the above
mentioned scrip(s) and therefore may be considered as interested. The views provided herein are general in nature and does not consider risk appetite or investment
objective of particular investor; readers are requested to take independent professional advice before investing. This should not be construed as invitation or solicitation
to do business with KSL. Kotak Securities Limited is also a Portfolio Manager. Portfolio Management Team (PMS) takes its investment decisions independent of the
PCG research and accordingly PMS may have positions contrary to the PCG research recommendation. Kotak Securities Limited does not provide any promise or
assurance of favourable view for a particular industry or sector or business group in any manner. The investor is requested to take into consideration all the risk factors
including their financial condition, suitability to risk return profile and take professional advice before investing.
The analyst for this report certifies that all of the views expressed in this report accurately reflect his or her personal views about the subject company or companies
and its or their securities, and no part of his or her compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this
report.
No part of this material may be duplicated in any form and/or redistributed without Kotak Securities' prior written consent.
Details of Associates are available on www.kotak.com
1. “Note that the research analysts contributing to the research report may not be registered/qualified as research analysts with FINRA; and
2. Such research analysts may not be associated persons of Kotak Mahindra Inc and therefore, may not be subject to NASD Rule 2711 restrictions on communications
with a subject company, public appearances and trading securities held by a research analyst account
Any U.S. recipients of the research who wish to effect transactions in any security covered by the report should do so with or through Kotak Mahindra Inc. (Member
FINRA/SIPC) and (ii) any transactions in the securities covered by the research by U.S. recipients must be effected only through Kotak Mahindra Inc. (Member
FINRA/SIPC) at 369 Lexington Avenue 28th Floor NY NY 10017 USA (Tel:+1 212-600-8850).
Kotak Securities Limited and its non US affiliates may, to the extent permissible under applicable laws, have acted on or used this research to the extent that it relates
to non US issuers, prior to or immediately following its publication. This material should not be construed as an offer to sell or the solicitation of an offer to buy any
security in any jurisdiction where such an offer or solicitation would be illegal. This research report and its respective contents do not constitute an offer or invitation
to purchase or subscribe for any securities or solicitation of any investments or investment services. Accordingly, any brokerage and investment services including the
products and services described are not available to or intended for Canadian persons or US persons.”
Research Analyst has served as an officer, director or employee of subject company(ies): No
We or our associates may have received compensation from the subject company(ies) in the past 12 months.
We or our associates have managed or co-managed public offering of securities for the subject company(ies) in the past 12 months: No
We or our associates may have received compensation for investment banking or merchant banking or brokerage services from the subject company(ies) in the past
12 months. We or our associates may have received any compensation for products or services other than investment banking or merchant banking or brokerage
services from the subject company(ies) in the past 12 months. We or our associates may have received compensation or other benefits from the subject company(ies)
or third party in connection with the research report. Our associates may have financial interest in the subject company(ies).
Research Analyst or his/her relative's financial interest in the subject company(ies): No
Kotak Securities Limited has financial interest in the subject company(ies) at the end of the month immediately preceding the date of publication of Research Report:
- Escorts, Sun Pharma, Federal Bank & GAIL - Yes
Nature of financial interest is holding of equity shares or derivatives of the subject company.
Our associates may have actual/beneficial ownership of 1% or more securities of the subject company(ies) at the end of the month immediately preceding the date of
publication of Research Report.
Research Analyst or his/her relatives has actual/beneficial ownership of 1% or more securities of the subject company(ies) at the end of the month immediately
preceding the date of publication of Research Report: No.
Kotak Securities Limited has actual/beneficial ownership of 1% or more securities of the subject company(ies) at the end of the month immediately preceding the date
of publication of Research Report: No
Kotak Securities – Private Client Group Please see the Disclosure/Disclaimer on the last page For Private Circulation 29
Subject company(ies) may have been client during twelve months preceding the date of distribution of the research report.
"A graph of daily closing prices of securities is available at https://www.nseindia.com/ChartApp/install/charts/mainpage.jsp and
http://economictimes.indiatimes.com/markets/stocks/stock-quotes. (Choose a company from the list on the browser and select the "three years" icon in the price
chart)."
Kotak Securities Limited. Registered Office: 27 BKC, C 27, G Block, Bandra Kurla Complex, Bandra (E), Mumbai 400051. CIN: U99999MH1994PLC134051, Telephone
No.: +22 43360000, Fax No.: +22 67132430. Website: www.kotak.com/www.kotaksecurities.com. Correspondence Address: Infinity IT Park, Bldg. No 21, Opp. Film City
Road, A K Vaidya Marg, Malad (East), Mumbai 400097. Telephone No: 42856825. SEBI Registration No: INZ000200137 (Member ID: NSE-08081; BSE-673; MSE-1024;
MCX-56285; NCDEX-1262), AMFI ARN 0164, PMS INP000000258 and Research Analyst INH000000586. NSDL/CDSL: IN-DP-NSDL-23-97. Our research should not be
considered as an advertisement or advice, professional or otherwise. The investor is requested to take into consideration all the risk factors including their financial
condition, suitability to risk return profile and the like and take professional advice before investing. Investments in securities market are subject to market risks, read
all the related documents carefully before investing. Derivatives are a sophisticated investment device. The investor is requested to take into consideration all the risk
factors before actually trading in derivative contracts. Compliance Officer Details: Mr. Manoj Agarwal. Call: 022 - 4285 8484, or Email: ks.compliance@kotak.com.
In case you require any clarification or have any concern, kindly write to us at below email ids:
Level 1: For Trading related queries, contact our customer service at 'service.securities@kotak.com' and for demat account related queries contact us at
ks.demat@kotak.com or call us on: Toll free numbers 18002099191 / 1860 266 9191
Level 2: If you do not receive a satisfactory response at Level 1 within 3 working days, you may write to us at ks.escalation@kotak.com or call us on 022-42858445
and if you feel you are still unheard, write to our customer service HOD at ks.servicehead@kotak.com or call us on 022-42858208.
Level 3: If you still have not received a satisfactory response at Level 2 within 3 working days, you may contact our Compliance Officer (Mr. Manoj Agarwal) at
ks.compliance@kotak.com or call on 91- (022) 4285 8484.
Level 4: If you have not received a satisfactory response at Level 3 within 7 working days, you may also approach Managing Director / CEO (Mr. Jaideep Hansraj)
at ceo.ks@kotak.com or call on 91-(022) 4285 8301.
Kotak Securities – Private Client Group Please see the Disclosure/Disclaimer on the last page For Private Circulation 30